There are two additional immunotherapy (vaccine) trials sponsored by Elicio Pharmaceutical. ELI-002-2P covers the KRAS G12D and G12R variants. ELI-002-7P (AMPLIFY) trial,is a pan-KRAS trial covering G12D, G12R and five other KRAS variants. More information on the trials can be obtained by calling PanCAN.org at 877.272.6226, M-F, 7:00am-5:00pm PT. A case manager can provide details on sites recruiting, contact details, eligibility/exclusion criteria.